Velanne Asset Management’s Zimmer Biomet ZBH Stock Holding History

Velanne Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,381	Closed	-$2.56M	–	19
2021 Q2	$2.56M	Sell	16,381 -40,016	-71%	-$6.48M	0.89%	20
2021 Q1	$8.77M	Sell	56,397 -58,628	-51%	-$9.08M	4.9%	11
2020 Q4	$17.2M	Sell	115,025 -6,367	-5%	-$899K	10.21%	2
2020 Q3	$16M	Hold	121,392	–	–	11.91%	1
2020 Q2	$14.1M	Sell	121,392 -3,585	-3%	-$413K	10.74%	1
2020 Q1	$12.3M	Buy	124,977 +23,871	+24%	+$3.13M	11.2%	1
2019 Q4	$14.7M	Buy	101,106 +49	+0%	+$6.76K	8.67%	1
2019 Q3	$13.5M	Buy	101,057 +5,034	+5%	+$650K	8.61%	2
2019 Q2	$11M	Buy	96,023 +1,535	+2%	+$180K	6.98%	3
2019 Q1	$11.7M	Buy	94,488 +3,720	+4%	+$423K	8.1%	1
2018 Q4	$9.14M	Buy	+90,768	New	+$10.2M	7.31%	3

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Velanne Asset Management's ZBH Position: Q3 2021 in Review

Velanne Asset Management sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 16,381 shares — an estimated $2.56M sold.

Velanne Asset Management first reported a position in ZBH in Q4 2018 and held it in 11 quarters. The position peaked at $17.2M in Q4 2020. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Velanne Asset Management reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Velanne Asset Management sold 16,381 Zimmer Biomet shares in Q3 2021, an estimated $2.56M.
Velanne Asset Management first reported a position in Zimmer Biomet in Q4 2018 and held it in 11 quarters.
Velanne Asset Management's Zimmer Biomet position peaked at $17.2M in Q4 2020.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Velanne Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.